Skip to main content
SpringerLink
Log in

Research misconduct—Have we reached the turning point at last?

  • Comment
  • Published:
Science and Engineering Ethics Aims and scope Submit manuscript

Abstract

The laissez-faire attitude towards dishonesty in research has simply created an environment for widespread escalation of the problem. Can we now believe anything we read? Why should we have confidence in an author because of his eminence? Should we automatically accept that clinical trials are always conducted with total integrity? Why have we been afraid to tackle this crisis head-on?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. MIPI, Medicolegal Investigations, Suite D5, Nup End Business Centre, Nup End Green, SG3 6QJ, Knebworth, Hertfordshire, UK

    Peter Jay

Authors
  1. Peter Jay
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Peter Jay is a Member of the Institute of Professional Investigators and co-founder of Medicolegal Investigations (MLI), an independent UK agency undertaking the detection and prosecution of clinical research fraud.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jay, P. Research misconduct—Have we reached the turning point at last?. SCI ENG ETHICS 5, 119–122 (1999). https://doi.org/10.1007/s11948-999-0058-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11948-999-0058-x

Keywords

Search

Navigation